John R Moore Edgewise Therapeutics, Inc. (EWTX) insider trading activity

John R Moore is General Counsel of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 3,252 shares of EWTX, which is worth approximately $110,568. The most recent transaction as insider was on Sep 23, 2024, when has been sold 20,922 shares (Common Stock) at a price of $27.63 per share, resulting in proceeds of $578,074. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.25K

0% 3M change

50.46% 12M change

Total Value Held $110,568

JOHN R MOORE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 23 2024	SELL Open market or private sale	$578,074 $27.63 p/Share	20,922 Reduced 86.55%	3,252 Common Stock
Sep 23 2024	BUY Exercise of conversion of derivative security	$14,854 $0.71 p/Share	20,922 Added 46.39%	24,174 Common Stock
Sep 20 2024	SELL Open market or private sale	$1,418,500 $28.37 p/Share	50,000 Reduced 93.89%	3,252 Common Stock
Sep 20 2024	BUY Exercise of conversion of derivative security	$35,500 $0.71 p/Share	50,000 Added 48.43%	53,252 Common Stock
May 02 2024	SELL Open market or private sale	$36,987 $18.91 p/Share	1,956 Reduced 37.56%	3,252 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	-	5,208 Added 50.0%	5,208 Common Stock
Feb 09 2024	SELL Open market or private sale	$160,660 $20.01 p/Share	8,029 Reduced 100.0%	0 Common Stock
Feb 09 2024	BUY Exercise of conversion of derivative security	$15,495 $1.93 p/Share	8,029 Added 50.0%	8,029 Common Stock
Feb 08 2024	SELL Open market or private sale	$76,298 $20.01 p/Share	3,813 Reduced 100.0%	0 Common Stock
Feb 08 2024	BUY Exercise of conversion of derivative security	$7,359 $1.93 p/Share	3,813 Added 50.0%	3,813 Common Stock
Feb 07 2024	SELL Open market or private sale	$359,860 $20.0 p/Share	17,993 Reduced 100.0%	0 Common Stock
Feb 07 2024	BUY Exercise of conversion of derivative security	$34,726 $1.93 p/Share	17,993 Added 50.0%	17,993 Common Stock
Dec 27 2023	SELL Open market or private sale	$89,218 $10.5 p/Share	8,497 Reduced 100.0%	0 Common Stock
May 02 2023	SELL Open market or private sale	$16,883 $8.9 p/Share	1,897 Reduced 22.42%	6,565 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	-	5,208 Added 38.1%	8,462 Common Stock
Oct 03 2022	SELL Open market or private sale	$46,165 $9.76 p/Share	4,730 Reduced 61.19%	3,000 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$9,129 $1.93 p/Share	4,730 Added 37.96%	7,730 Common Stock
Sep 06 2022	SELL Open market or private sale	$51,604 $10.91 p/Share	4,730 Reduced 61.19%	3,000 Common Stock
Sep 06 2022	BUY Exercise of conversion of derivative security	$9,129 $1.93 p/Share	4,730 Added 37.96%	7,730 Common Stock
Aug 03 2022	SELL Open market or private sale	$85,950 $9.31 p/Share	9,232 Reduced 75.47%	3,000 Common Stock
Aug 03 2022	BUY Exercise of conversion of derivative security	$12,186 $1.32 p/Share	9,232 Added 43.01%	12,232 Common Stock
Jul 06 2022	SELL Open market or private sale	$8,933 $8.54 p/Share	1,046 Reduced 25.85%	3,000 Common Stock
Jul 06 2022	BUY Exercise of conversion of derivative security	$2,019 $1.93 p/Share	1,046 Added 20.54%	4,046 Common Stock
Jul 05 2022	SELL Open market or private sale	$68,353 $8.35 p/Share	8,186 Reduced 73.18%	3,000 Common Stock
Jul 05 2022	BUY Exercise of conversion of derivative security	$10,806 $1.32 p/Share	8,186 Added 42.26%	11,186 Common Stock

JRM

John R Moore

General Counsel

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Value

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edgewise Therapeutics, Inc.

Track Activities on EWTX

Account